A pharmaceutical study on aripiprazole / Aly Ahmed Abdelbary ; Supervised Abdelhalim Elassasy , Mohamed Elnabarawi , Bhaskara Jasti
Material type:
- دراسة صيدلية على عقار الأريبيبرازول [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.Ph.D.2011.Al.P (Browse shelf(Opens below)) | Not for loan | 01010110057263000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.Ph.D.2011.Al.P (Browse shelf(Opens below)) | 57263.CD | Not for loan | 01020110057263000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.08.08.Ph.D.2010.So.P A pharmaceutical study of certain anti-emetic drug in modified oral dosage forms / | Cai01.08.08.Ph.D.2011.Ah.N Niosomal encapsulation of nystatin for increasing its efficacy and safety / | Cai01.08.08.Ph.D.2011.Ah.N Niosomal encapsulation of nystatin for increasing its efficacy and safety / | Cai01.08.08.Ph.D.2011.Al.P A pharmaceutical study on aripiprazole / | Cai01.08.08.Ph.D.2011.Al.P A pharmaceutical study on aripiprazole / | Cai01.08.08.Ph.D.2011.Ha.F Formulation and Evaluation of certain antihypertensive drug in specific dosage form / | Cai01.08.08.Ph.D.2011.Ha.F Formulation and Evaluation of certain antihypertensive drug in specific dosage form / |
Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceuties
Nanomilling refers to an attrition process where the particle size of the drug is reduced down to the submicron range by media milling of the drug crystals in water - based stabilizer solution . These nanoformulations offer increased dissolution rates for drug compounds with poor aqueous solubility ( BCS class II and IV ) and consequently enhance their bioavailability
Issued also as CD
There are no comments on this title.